The results are very good - I'm not sure how you can interpret them any other way.
The market was expecting the Europe results to be garbage and they are actually not too bad.
The RoW results are great. North America is a key growth market and any nerves about Trump and Government cutting travel spending appear to be overblown - As per guidance, this area represents a significant growth opportunity and with the AUD/ USD exchange rate, the outlook is appears to be pretty optimistic.
Europe was always going to be a drag, but they are better than what I was expecting.
- Forums
- ASX - By Stock
- CTD
- Ann: Profit Guidance
CTD
corporate travel management limited
Add to My Watchlist
2.18%
!
$13.47

Ann: Profit Guidance, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.47 |
Change
-0.300(2.18%) |
Mkt cap ! $1.971B |
Open | High | Low | Value | Volume |
$13.85 | $14.00 | $13.47 | $6.529M | 477.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3483 | $13.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.59 | 92 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.460 |
1 | 500 | 13.350 |
1 | 750 | 13.310 |
1 | 1000 | 13.130 |
2 | 4000 | 13.000 |
Price($) | Vol. | No. |
---|---|---|
13.590 | 92 | 1 |
13.990 | 500 | 1 |
14.000 | 3298 | 7 |
14.050 | 2135 | 1 |
14.100 | 2290 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
CTD (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online